This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Mike Nichols, PhD
Principal Scientist, AI Protein Design at Manifold Bio
Speaker

Profile

Mike Nichols, PhD is a Principal Scientist in AI Protein Design at Manifold Bio, a biotechnology company pioneering tissue-targeted medicines, designed in vivo. He works on the mBER team, developing de novo antibody design systems that combine machine learning with structural biology. His work spans computational binder design and large-scale experimental analysis, generating designs that fuel Manifold's in vivo discovery pipeline. Mike has contributed to the validation of over one million computationally designed antibodies across hundreds of targets. He earned his PhD in Genetics and Molecular Biology from Emory University, where he applied machine learning to genomic architecture prediction.

Agenda Sessions

  • mBER: Controllable de novo Antibody Design with Million-scale Experimental Screening

    11:30